The Latest Cardiac and Vascular News
SILVER SPRING, Md., May 04, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today reported financial results for the three months ended March 31, 2021. Recent Highlights Recorded […]
SILVER SPRING, Md., April 28, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced today the initiation of a multi-center observational study to provide insight into the clinical […]
SILVER SPRING, Md., March 01, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today reported financial results for the fourth quarter and full year ended December 31, 2020. […]
SILVER SPRING, Md., Feb. 17, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced today the first patient enrolled in the HEAL Study, investigating the biologic and clinical […]
SILVER SPRING, Md., Nov. 19, 2020 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today reported financial results for the three and nine months ended September 30, 2020. Recent […]
SILVER SPRING, Md., Sept. 28, 2020 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced today that Matthew Ferguson has been appointed Chief Financial Officer (CFO), effective immediately. “We are […]
SILVER SPRING, Md.–(BUSINESS WIRE)–Aziyo® Biologics, Inc., a fully integrated regenerative medicine company, today announced the publication of results from its landmark RECON study in the Journal of Cardiothoracic Surgery1. The prospective, single arm study included 1,420 patients in 42 hospitals across the United States and represents the largest pericardial-closure study conducted to date. […]
SILVER SPRING, Md.–(BUSINESS WIRE)–Aziyo Biologics, Inc., a fully integrated regenerative medicine company, announced today the appointment of Ronald (Ron) Lloyd as President and Chief Executive Officer of the company. Mr. Lloyd will be based in the Silver Spring, Maryland office with responsibility for all aspects of the rapidly growing Aziyo […]
SILVER SPRING, Md.–(BUSINESS WIRE)–Aziyo Biologics, Inc., a fully integrated regenerative medicine company, today announced that it has entered into a US co-distribution agreement for its CanGaroo® Bio Envelope with BIOTRONIK, Inc., a global leader in cardio- and endovascular medical technology. CanGaroo Bio Envelopes are a natural extracellular matrix (ECM) scaffold that […]
SILVER SPRING, Md.–(BUSINESS WIRE)– Aziyo Biologics, a fully integrated regenerative medicine company, today announced positive results from PERFORM, a prospective, post-market study conducted in patients undergoing femoral arterial reconstruction using the company’s biologic extracellular matrix (ECM) scaffold. There were no device-related adverse events or infections and primary patency was maintained in 97.6% of […]
